Aclaris Therapeutics
+$0.91 (+6.58%) Today
-$0.01 (-0.07%) As of 8:28 PM UTC after-hours
Why Robinhood?
Robinhood gives you the tools you need to put your money in motion. You can buy or sell ACRS and other ETFs, options, and stocks.
About ACRS
Aclaris Therapeutics, Inc. operates as a dermatologist-led biopharmaceutical company, which engages in identifying, developing, and commercializing novel drugs to address the needs in medical and aesthetic dermatology and immunology. It operates through the Therapeutics and Contract Research segments.
CEO
Neal S. Walker
Employees
77
Headquarters
Wayne, Pennsylvania
Founded
2012
ACRS Key Statistics
Market cap
981.42M
Price-Earnings ratio
—
Dividend yield
—
Average volume
582.90K
High today
$14.76
Low today
$13.45
Open price
$13.68
Volume
435.47K
52 Week high
$19.97
52 Week low
$9.26
ACRS News
Simply Wall StJul 4
Aclaris Therapeutics, Inc. insiders who sold US$1.6m worth of stock earlier this year are probably glad they did so as market cap slides to US$921m - Simply Wall St
Insiders seem to have made the most of their holdings by selling US$1.6m worth of Aclaris Therapeutics, Inc. ( ) stock at an average sell price of US$15.68 duri
Analyst ratings
100%
of 6 ratings
Buy
100%
Hold
0%
Sell
0%
ACRS Earnings
-$0.57
-$0.38
-$0.19
$0.00
Q4 FY20
Q1 FY21
Q2 FY21
Q3 FY21
Q4 FY21
Q1 FY22
Q2 FY22
Estimated
— per share
Actual
Expected Aug 4, Pre-Market